Key Takeaway
The new portfolio, designed for the AI era, aligns with the DOE’s mission to enhance U.S. leadership in AI and supercomputing across various sectors. It supports the U.S. AI Action Plan for secure national AI infrastructure. Antonio Neri, HPE’s CEO, emphasized the importance of this initiative, building on the success of the Frontier supercomputer. The new system, Discovery, utilizes the HPE Cray Supercomputing GX5000 platform and next-gen AMD EPYC CPUs and GPUs. It aims to boost research productivity tenfold, facilitating advancements in precision medicine, cancer research, nuclear energy, and aerospace.
This new portfolio is designed for the AI era and aligns with the DOE’s mission to enhance American leadership in AI and supercomputing across various fields, including science, energy, and national security.
The systems also support the US AI Action Plan’s initiative for secure and sovereign national AI infrastructure.
“When we developed Frontier for Oak Ridge National Laboratory and achieved exascale computing, we reached a milestone in supercomputing history and a significant accomplishment for the US,” stated Antonio Neri, President and CEO at HPE.
“We take pride in building on that innovative leadership and strong public-private partnership with the U.S. Department of Energy, ORNL, and AMD to create Discovery and Lux, propelling the next era of scientific discovery and AI innovation.”
Inside the exascale Discovery
Discovery follows in the footsteps of ORNL’s Frontier — the HPE-built machine that was the world’s first exascale supercomputer, capable of performing two quintillion calculations per second.
It will utilize the new HPE Cray Supercomputing GX5000 platform, which incorporates a unified AI and High Performance Computing (HPC) architecture.
Discovery will also include HPE Cray Supercomputing Storage Systems K3000 and will be powered by next-generation AMD EPYC CPUs (“Venice”) and AMD Instinct™ MI430X GPUs.
Discovery is anticipated to boost research productivity tenfold, facilitating advancements in precision medicine, cancer research, nuclear energy, and aerospace.



